Showing results (231-240 of 250) with videos related to
Sort By:
Pageof 25
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2024
Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European CountriesChristopher Kruse, Anna Lipinski, Malte Verheyen, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2008
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 2, 2023
Apathy in patients with Alzheimer's disease is a cost-driving factorChristopher Kruse, Franziska Maier, Annika Spottke, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2009
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)Richard Dodel, Annika Spottke, Alexander Gerhard, et al.Journal of Parkinson'S Disease|January 24, 2022
Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's DiseaseJennifer Michels, Hendrik van der Wurp, Elke Kalbe, et al.Translational Neurodegeneration|April 16, 2019
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptorsFranziska Hopfner, Stefanie H Müller, Dagmar Steppat, et al.Pageof 25